Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in March 2020

View ORCID ProfileMarjolein F.Q. Kluytmans-van den Bergh, Anton G.M. Buiting, View ORCID ProfileSuzan D. Pas, View ORCID ProfileRobbert G. Bentvelsen, View ORCID ProfileWouter van den Bijllaardt, Anne J.G. van Oudheusden, Miranda M.L. van Rijen, Jaco J. Verweij, View ORCID ProfileMarion P.G. Koopmans, View ORCID ProfileJan A.J.W. Kluytmans
doi: https://doi.org/10.1101/2020.03.23.20041913
Marjolein F.Q. Kluytmans-van den Bergh
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
2Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands
3Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marjolein F.Q. Kluytmans-van den Bergh
  • For correspondence: marjoleinkluytmans@gmail.com
Anton G.M. Buiting
4Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
5Department of Infection Control, Elisabeth-TweeSteden Hospital, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzan D. Pas
6Microvida Laboratory for Microbiology, Bravis Hospital, Roosendaal, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Suzan D. Pas
Robbert G. Bentvelsen
7Microvida Laboratory for Microbiology, Amphia Hospital, Breda, the Netherlands
8Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robbert G. Bentvelsen
Wouter van den Bijllaardt
7Microvida Laboratory for Microbiology, Amphia Hospital, Breda, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wouter van den Bijllaardt
Anne J.G. van Oudheusden
5Department of Infection Control, Elisabeth-TweeSteden Hospital, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miranda M.L. van Rijen
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaco J. Verweij
4Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion P.G. Koopmans
9Department of Virology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marion P.G. Koopmans
Jan A.J.W. Kluytmans
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
3Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
6Microvida Laboratory for Microbiology, Bravis Hospital, Roosendaal, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan A.J.W. Kluytmans
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background On February 27, 2020, the first patient with COVID-19 was reported in the Netherlands. During the following weeks, nine healthcare workers (HCWs) were diagnosed with COVID-19 in two Dutch teaching hospitals, eight of whom had no history of travel to China or Northern-Italy. A low-threshold screening regimen was implemented to determine the prevalence and clinical presentation of COVID-19 among HCWs in these two hospitals.

Methods HCWs who suffered from fever or respiratory symptoms were voluntarily tested for SARS-CoV-2 by real-time reverse-transcriptase PCR on oropharyngeal samples. Structured interviews were conducted to document symptoms for all HCWs with confirmed COVID-19.

Findings Thirteen-hundred fifty-three (14%) of 9,705 HCWs employed were tested, 86 (6%) of whom were infected with SARS-CoV-2. Most HCWs suffered from relatively mild disease and only 46 (53%) reported fever. Eighty (93%) HCWs met a case definition of fever and/or coughing and/or shortness of breath. None of the HCWs identified through the screening reported a travel history to China or Northern Italy, and 3 (3%) reported to have been exposed to an inpatient known with COVID-19 prior to the onset of symptoms.

Interpretation Within two weeks after the first Dutch case was detected, a substantial proportion of HCWs with fever or respiratory symptoms were infected with SARS-CoV-2, probably caused by acquisition of the virus in the community during the early phase of local spread. The high prevalence of mild clinical presentations, frequently not including fever, asks for less stringent use of the currently recommended case-definition for suspected COVID-19.

Evidence before this study This study was conducted in response to the global spread of SARS-CoV-2, and the detection of eight healthcare workers (HCWs) in two Dutch teaching hospitals within two weeks after the first patient with COVID-19 was detected in the Netherlands who had no history of travel to China or Northern-Italy, raising the question of whether undetected community circulation was occurring.

Added value of this study To the best of our knowledge, this report is the first to describe the prevalence, the clinical presentation and early outcomes of COVID-19 in HCWs, which may be helpful for others seeking to identify HCWs suspected for COVID-19 in an outbreak situation.

Implications of all the available evidence We describe that within two weeks after the first Dutch case was detected, a substantial proportion of HCWs with fever or (mild) respiratory symptoms were infected with SARS-CoV-2, probably caused by acquisition of the virus in the community during the early phase of local spread. The high prevalence of mild clinical presentations, frequently not including fever, asks for less stringent use of the currently recommended case-definition for suspected COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

MKo participates in the RECOVER project that is funded by the European Commission under H2020 call SC1-PHE-CORONAVIRUS-2020.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data analysed are available from the presenting author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted March 31, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in March 2020
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in March 2020
Marjolein F.Q. Kluytmans-van den Bergh, Anton G.M. Buiting, Suzan D. Pas, Robbert G. Bentvelsen, Wouter van den Bijllaardt, Anne J.G. van Oudheusden, Miranda M.L. van Rijen, Jaco J. Verweij, Marion P.G. Koopmans, Jan A.J.W. Kluytmans
medRxiv 2020.03.23.20041913; doi: https://doi.org/10.1101/2020.03.23.20041913
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in March 2020
Marjolein F.Q. Kluytmans-van den Bergh, Anton G.M. Buiting, Suzan D. Pas, Robbert G. Bentvelsen, Wouter van den Bijllaardt, Anne J.G. van Oudheusden, Miranda M.L. van Rijen, Jaco J. Verweij, Marion P.G. Koopmans, Jan A.J.W. Kluytmans
medRxiv 2020.03.23.20041913; doi: https://doi.org/10.1101/2020.03.23.20041913

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (199)
  • Anesthesia (54)
  • Cardiovascular Medicine (492)
  • Dentistry and Oral Medicine (90)
  • Dermatology (57)
  • Emergency Medicine (169)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (214)
  • Epidemiology (5722)
  • Forensic Medicine (3)
  • Gastroenterology (217)
  • Genetic and Genomic Medicine (872)
  • Geriatric Medicine (89)
  • Health Economics (232)
  • Health Informatics (768)
  • Health Policy (395)
  • Health Systems and Quality Improvement (254)
  • Hematology (105)
  • HIV/AIDS (185)
  • Infectious Diseases (except HIV/AIDS) (6527)
  • Intensive Care and Critical Care Medicine (393)
  • Medical Education (118)
  • Medical Ethics (28)
  • Nephrology (93)
  • Neurology (851)
  • Nursing (44)
  • Nutrition (142)
  • Obstetrics and Gynecology (164)
  • Occupational and Environmental Health (263)
  • Oncology (516)
  • Ophthalmology (165)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (252)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (981)
  • Public and Global Health (2250)
  • Radiology and Imaging (378)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (313)
  • Rheumatology (109)
  • Sexual and Reproductive Health (82)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)